Insider trades › Gilead › Dietmar Berger
Dietmar Berger: Gilead stock transactions
Dietmar Berger (Chief Medical Officer at Gilead) reported 2 transactions in GILD stock on SEC Form 4 over the last 120 days. Name as filed with the SEC: Berger Dietmar.
$0open-market sales (0 shares)
$0open-market purchases (0 shares)
2026-09-10most recent transaction
Transactions
| Date | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Sep 10, 2026 | Option or RSU exercise | 533 | — | — | Form 4 ↗ |
| Sep 10, 2026 | Shares withheld for tax | 263 | $144.81 | — | Form 4 ↗ |
Source: SEC EDGAR Form 4 filings; each row links to the filing. Sales marked "10b5-1 plan" were reported as made under a pre-arranged trading plan. Insider trades are reported facts, not recommendations. Not investment advice.